Valneva SE (VALN) EBT Margin (2021 - 2026)
Valneva SE (VALN) posted quarterly EBT Margin of 101.12% for Q1 2026, down 8536.0% year-on-year from 1.2% in Q1 2025, and up 23.79% on a QoQ basis from 132.67% in Q4 2025.
Valneva SE (VALN) EBT Margin (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported EBT Margin for 6 consecutive years, with 101.12% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin fell 8536.0% year-over-year to 101.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 98.59% (down 5512.0% YoY) and the FY2025 annual result came in at 72.27%, down 6524.0% from the prior year.
- EBT Margin grew to 101.12% in Q1 2026 per VALN's latest filing, from 132.67% in the prior quarter.
- Over the last five years, EBT Margin for VALN reached as high as 179.89% in Q1 2024 and fell as low as 201.3% in Q2 2022.
- A 5-year average of 60.28% and a median of 63.68% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin jumped 75573 bps — and 2025, when it sank 19564 bps.
- Year by year, EBT Margin stood at 43.0% in 2022, then slumped by 57 bps to 67.44% in 2023, then increased by 6 bps to 63.68% in 2024, then slumped by 108 bps to 132.67% in 2025, then grew by 24 bps to 101.12% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 101.12%, 132.67%, and 199.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -101.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.12% |
| Dec 31, 2025 | -132.67% |
| Sep 30, 2025 | -199.07% |
| Jun 30, 2025 | -24.43% |
| Mar 31, 2025 | -15.76% |
| Dec 31, 2024 | -63.68% |
| Sep 30, 2024 | -31.08% |
| Jun 30, 2024 | -65.95% |
| Mar 31, 2024 | 179.89% |
| Dec 31, 2023 | -67.44% |
| Sep 30, 2023 | -82.87% |
| Jun 30, 2023 | -51.14% |
| Mar 31, 2023 | -54.46% |
| Dec 31, 2022 | -43.00% |
| Sep 30, 2022 | 46.15% |
| Jun 30, 2022 | -201.30% |
| Mar 31, 2022 | -116.90% |
| Dec 31, 2021 | 62.65% |
| Sep 30, 2021 | -709.58% |
| Jun 30, 2021 | -237.41% |